NZ744131A - Tumor-infiltrating lymphocytes for adoptive cell therapy - Google Patents

Tumor-infiltrating lymphocytes for adoptive cell therapy

Info

Publication number
NZ744131A
NZ744131A NZ744131A NZ74413115A NZ744131A NZ 744131 A NZ744131 A NZ 744131A NZ 744131 A NZ744131 A NZ 744131A NZ 74413115 A NZ74413115 A NZ 74413115A NZ 744131 A NZ744131 A NZ 744131A
Authority
NZ
New Zealand
Prior art keywords
tumor
cell therapy
adoptive cell
infiltrating lymphocytes
disclosed
Prior art date
Application number
NZ744131A
Inventor
Amod A Sarnaik
Shari Pilon-Thomas
Mark Mclaughlin
Hao Liu
Original Assignee
H Lee Moffitt Cancer Ct & Res
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lee Moffitt Cancer Ct & Res, Univ South Florida filed Critical H Lee Moffitt Cancer Ct & Res
Publication of NZ744131A publication Critical patent/NZ744131A/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Disclosed are compositions and methods for ex vivo expansion of tumorinfiltrating lymphocytes for use in adoptive cell therapy (ACT). Also disclosed are compositions and method for identifying an agent for ex vivo expansion of tumorinfiltrating lymphocytes for use in ACT. Also disclosed are methods for treating cancer using tumor-infiltrating lymphocytes expanded by the disclosed methods.
NZ744131A 2014-03-20 2015-03-20 Tumor-infiltrating lymphocytes for adoptive cell therapy NZ744131A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461955970P 2014-03-20 2014-03-20
US201461973002P 2014-03-31 2014-03-31
NZ72522715 2015-03-20

Publications (1)

Publication Number Publication Date
NZ744131A true NZ744131A (en) 2023-07-28

Family

ID=87654781

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ744131A NZ744131A (en) 2014-03-20 2015-03-20 Tumor-infiltrating lymphocytes for adoptive cell therapy

Country Status (1)

Country Link
NZ (1) NZ744131A (en)

Similar Documents

Publication Publication Date Title
MX2020005634A (en) Tumor-infiltrating lymphocytes for adoptive cell therapy.
GB2557123A (en) Modified cells and methods of therapy
MX2017012206A (en) Ex vivo proliferation of epithelial cells.
NZ731467A (en) Anti-tim3 antibodies and methods of use
PH12017500803A1 (en) Anti-pd-1 antibodies
MX2018010473A (en) Combination therapy with anti-cd73 antibodies.
TW201613648A (en) Compounds and compositions for immunotherapy
GB201510771D0 (en) Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
MX2021006734A (en) Method for treating cancer.
MX2019003616A (en) SC-ß CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME.
GB2570593A (en) Methods relating to intestinal organ-on-a-chip
HK1253531A1 (en) Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers
MY189857A (en) Methods of selecting t cell line and donor thereof for adoptive cellular therapy
MX2017014735A (en) Pd-l1 promoter methylation in cancer.
MX2018002344A (en) Method for treating cancer.
TW201612308A (en) Collector architecture layout design
MX2015013177A (en) Combination cancer treatments utilizing micrornas and egfr-tki inhibitors.
MX2017006015A (en) Apilimod for use in the treatment of renal cancer.
PH12018502303A1 (en) Compositions and methods for bioengineered tissues
PH12016501422A1 (en) Functionalised benzopyran compounds and use thereof
EP3645708A4 (en) Compositions and methods for adoptive cell therapy for cancer
PL3460052T3 (en) Improved allogeneic dendritic cells for use in cancer treatment
EP3645020A4 (en) Compositions and methods for adoptive cell therapy
EP3645019A4 (en) Compositions and methods for adoptive cell therapy
NZ744131A (en) Tumor-infiltrating lymphocytes for adoptive cell therapy

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 MAR 2025 BY COMPUTER PACKAGES INC

Effective date: 20240229